BRAF V600E and V600K in Melanoma: Clinicopathologic Correlation

被引：0
|
作者：
Purgina, B. M. [1 ]
Jelic, T. [1 ]
Chiosea, S. I. [1 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
来源：
MODERN PATHOLOGY | 2012年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
535
引用
收藏
页码：131A / 131A
页数：1
相关论文
共 50 条
  • [41] A role for immunohistochemical detection of BRAF V600E in metastatic melanoma?
    Lade-Keller, J.
    Kristensen, L. S.
    Riber-Hansen, R.
    Guldberg, P.
    Hansen, L. L.
    Steiniche, T.
    Hager, H.
    APMIS, 2013, 121 : 7 - 7
  • [42] Braf V600E mutation in melanoma: translational current scenario
    Guadarrama-Orozco, J. A.
    Ortega-Gomez, A.
    Ruiz-Garcia, E. B.
    Astudillo-de la Vega, H.
    Meneses-Garcia, A.
    Lopez-Camarillo, C.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (09): : 863 - 871
  • [43] Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
    Sun, Chong
    Wang, Liqin
    Huang, Sidong
    Heynen, Guus J. J. E.
    Prahallad, Anirudh
    Robert, Caroline
    Haanen, John
    Blank, Christian
    Wesseling, Jelle
    Willems, Stefan M.
    Zecchin, Davide
    Hobor, Sebastijan
    Bajpe, Prashanth K.
    Lieftink, Cor
    Mateus, Christina
    Vagner, Stephan
    Grernrum, Wipawadee
    Hofland, Ingrid
    Schlicker, Andreas
    Wessels, Lodewyk F. A.
    Beijersbergen, Roderick L.
    Bardelli, Alberto
    Di Nicolantonio, Federica
    Eggermont, Alexander M. M.
    Bernards, Rene
    NATURE, 2014, 508 (7494) : 118 - +
  • [44] Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
    Chong Sun
    Liqin Wang
    Sidong Huang
    Guus J. J. E. Heynen
    Anirudh Prahallad
    Caroline Robert
    John Haanen
    Christian Blank
    Jelle Wesseling
    Stefan M. Willems
    Davide Zecchin
    Sebastijan Hobor
    Prashanth K. Bajpe
    Cor Lieftink
    Christina Mateus
    Stephan Vagner
    Wipawadee Grernrum
    Ingrid Hofland
    Andreas Schlicker
    Lodewyk F. A. Wessels
    Roderick L. Beijersbergen
    Alberto Bardelli
    Federica Di Nicolantonio
    Alexander M. M. Eggermont
    Rene Bernards
    Nature, 2014, 508 : 118 - 122
  • [45] Prospective immunohistochemical analysis of BRAF V600E mutation in melanoma
    Thiel, Alexandra
    Moza, Monica
    Kytola, Soili
    Orpana, Arto
    Jahkola, Tiina
    Hernberg, Micaela
    Virolainen, Susanna
    Ristimaki, Ari
    HUMAN PATHOLOGY, 2015, 46 (02) : 169 - 175
  • [46] Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
    Chapman, Paul B.
    Hauschild, Axel
    Robert, Caroline
    Haanen, John B.
    Ascierto, Paolo
    Larkin, James
    Dummer, Reinhard
    Garbe, Claus
    Testori, Alessandro
    Maio, Michele
    Hogg, David
    Lorigan, Paul
    Lebbe, Celeste
    Jouary, Thomas
    Schadendorf, Dirk
    Ribas, Antoni
    O'Day, Steven J.
    Sosman, Jeffrey A.
    Kirkwood, John M.
    Eggermont, Alexander M. M.
    Dreno, Brigitte
    Nolop, Keith
    Li, Jiang
    Nelson, Betty
    Hou, Jeannie
    Lee, Richard J.
    Flaherty, Keith T.
    McArthur, Grant A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26): : 2507 - 2516
  • [47] Prospective immunohistochemical analysis of BRAF V600E mutation in melanoma
    Ristimaki, A.
    Thiel, A.
    Moza, M.
    Kytola, S.
    Orpana, A.
    Jahkola, T.
    Hernberg, M.
    Virolainen, S.
    VIRCHOWS ARCHIV, 2014, 465 : S318 - S318
  • [48] Analysis of the BRAF V600E mutation in primary cutaneous melanoma
    Inumaru, J. S. S.
    Gordo, K. I. F.
    Fraga Junior, A. C.
    Silva, A. M. T. C.
    Leal, C. B. Q. S.
    Ayres, F. M.
    Wastowski, I. J.
    Borges, N. F.
    Saddi, V. A.
    GENETICS AND MOLECULAR RESEARCH, 2014, 13 (02) : 2840 - 2848
  • [49] Multifocal BRAF(V600E)-Mutated Melanoma in situ on the Foot
    Iwama, Eimei
    Fujimura, Taku
    Kusakari, Yoshiyuki
    Haga, Takahiro
    Aiba, Setsuya
    CASE REPORTS IN DERMATOLOGY, 2015, 7 (03): : 322 - 327
  • [50] Braf V600E mutation in melanoma: translational current scenario
    J. A. Guadarrama-Orozco
    A. Ortega-Gómez
    E. B. Ruiz-García
    H. Astudillo-de la Vega
    A. Meneses-García
    C. Lopez-Camarillo
    Clinical and Translational Oncology, 2016, 18 : 863 - 871
12345